Safety and immunogenicity of SYS6006 were evaluated in healthy adults after three doses of COVID-19 inactivated vaccines
This item is under embargo and is only visible to journalists
Please login here
Regions: Asia, China, Europe, United Kingdom
Keywords: , Covid-19, Science, Life Sciences, Health, Medical
The item has been withdrawn. If you are a journalists please contact the person that posted the item with any questions.